IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
26 hedge funds and large institutions have $36.5M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.41M | |
| 2 | +$740K | |
| 3 | +$120K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$97.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$30.8K |
Top Sellers
| 1 | -$2.54M | |
| 2 | -$219K | |
| 3 | -$74K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$70.9K |
| 5 |
LMF
LMR Master Fund
Grand Cayman,
Cayman Islands
|
-$58K |